Cargando…

Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes

AIM: There is a wide variety of cardiovascular outcomes in patients with type 2 diabetes (T2DM), even in asymptomatic individuals. Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis and can be considered as a predictor of cardiovascular risk (CVR). The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Palma, Cátia Cristina Silva Sousa Vergara, Lopes, Pablo Moura, Silva, Eliete Leão Clemente, Bevilaqua, Maria de Fátima da Matta, Bomfim, Alfredo de Souza, Gomes, Marilia Brito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369301/
https://www.ncbi.nlm.nih.gov/pubmed/32765029
http://dx.doi.org/10.2147/DMSO.S251780
_version_ 1783560752545660928
author Palma, Cátia Cristina Silva Sousa Vergara
Lopes, Pablo Moura
Silva, Eliete Leão Clemente
Bevilaqua, Maria de Fátima da Matta
Bomfim, Alfredo de Souza
Gomes, Marilia Brito
author_facet Palma, Cátia Cristina Silva Sousa Vergara
Lopes, Pablo Moura
Silva, Eliete Leão Clemente
Bevilaqua, Maria de Fátima da Matta
Bomfim, Alfredo de Souza
Gomes, Marilia Brito
author_sort Palma, Cátia Cristina Silva Sousa Vergara
collection PubMed
description AIM: There is a wide variety of cardiovascular outcomes in patients with type 2 diabetes (T2DM), even in asymptomatic individuals. Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis and can be considered as a predictor of cardiovascular risk (CVR). The aim of this study was to evaluate the relationship between CIMT-determined vascular age (VA), CVR scores, and thyroid function in asymptomatic patients with T2DM. PATIENTS AND METHODS: Clinical laboratory and CIMT parameters were measured in 154 asymptomatic patients with T2DM. The Framingham risk score (FRS) was performed with chronological age (CA) and with VA. A multinomial logistic regression model was used to analyze variables related to CVR reclassification. RESULTS: The use of CIMT-determined VA led to the reclassification of 54 (35.52%) out of 152 asymptomatic T2DM patients, being 20 (37.03%) to a lower categorical risk and 34 (62.96%) to a higher categorical risk according to FRS. The variables that were associated to reclassification to a higher categorical risk were positive family history (FH) of premature coronary artery disease (p=0.046), FH of thyroid disease (p=0.010), use of statins (p=0.027), and free T4 levels (p=0.009). CONCLUSION: VA determined from CIMT allowed the reclassification of the CVR in asymptomatic T2DM patients. FH of premature CAD, FH of known thyroid disease, use of statins, and free T4 levels were associated to a reclassification into a higher risk category. The use of doppler to perform CIMT measure is currently more accessible, especially in a low-middle income country like Brazil. However, further prospective studies must be performed to establish the predictive values of CIMT on atherosclerosis and how thyroid function acts like cardiovascular risk marker on CVR scores.
format Online
Article
Text
id pubmed-7369301
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73693012020-08-05 Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes Palma, Cátia Cristina Silva Sousa Vergara Lopes, Pablo Moura Silva, Eliete Leão Clemente Bevilaqua, Maria de Fátima da Matta Bomfim, Alfredo de Souza Gomes, Marilia Brito Diabetes Metab Syndr Obes Original Research AIM: There is a wide variety of cardiovascular outcomes in patients with type 2 diabetes (T2DM), even in asymptomatic individuals. Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis and can be considered as a predictor of cardiovascular risk (CVR). The aim of this study was to evaluate the relationship between CIMT-determined vascular age (VA), CVR scores, and thyroid function in asymptomatic patients with T2DM. PATIENTS AND METHODS: Clinical laboratory and CIMT parameters were measured in 154 asymptomatic patients with T2DM. The Framingham risk score (FRS) was performed with chronological age (CA) and with VA. A multinomial logistic regression model was used to analyze variables related to CVR reclassification. RESULTS: The use of CIMT-determined VA led to the reclassification of 54 (35.52%) out of 152 asymptomatic T2DM patients, being 20 (37.03%) to a lower categorical risk and 34 (62.96%) to a higher categorical risk according to FRS. The variables that were associated to reclassification to a higher categorical risk were positive family history (FH) of premature coronary artery disease (p=0.046), FH of thyroid disease (p=0.010), use of statins (p=0.027), and free T4 levels (p=0.009). CONCLUSION: VA determined from CIMT allowed the reclassification of the CVR in asymptomatic T2DM patients. FH of premature CAD, FH of known thyroid disease, use of statins, and free T4 levels were associated to a reclassification into a higher risk category. The use of doppler to perform CIMT measure is currently more accessible, especially in a low-middle income country like Brazil. However, further prospective studies must be performed to establish the predictive values of CIMT on atherosclerosis and how thyroid function acts like cardiovascular risk marker on CVR scores. Dove 2020-07-14 /pmc/articles/PMC7369301/ /pubmed/32765029 http://dx.doi.org/10.2147/DMSO.S251780 Text en © 2020 Palma et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Palma, Cátia Cristina Silva Sousa Vergara
Lopes, Pablo Moura
Silva, Eliete Leão Clemente
Bevilaqua, Maria de Fátima da Matta
Bomfim, Alfredo de Souza
Gomes, Marilia Brito
Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
title Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
title_full Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
title_fullStr Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
title_full_unstemmed Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
title_short Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
title_sort vascular age as a cardiovascular risk marker in asymptomatic patients with type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369301/
https://www.ncbi.nlm.nih.gov/pubmed/32765029
http://dx.doi.org/10.2147/DMSO.S251780
work_keys_str_mv AT palmacatiacristinasilvasousavergara vascularageasacardiovascularriskmarkerinasymptomaticpatientswithtype2diabetes
AT lopespablomoura vascularageasacardiovascularriskmarkerinasymptomaticpatientswithtype2diabetes
AT silvaelieteleaoclemente vascularageasacardiovascularriskmarkerinasymptomaticpatientswithtype2diabetes
AT bevilaquamariadefatimadamatta vascularageasacardiovascularriskmarkerinasymptomaticpatientswithtype2diabetes
AT bomfimalfredodesouza vascularageasacardiovascularriskmarkerinasymptomaticpatientswithtype2diabetes
AT gomesmariliabrito vascularageasacardiovascularriskmarkerinasymptomaticpatientswithtype2diabetes